Xu Xiao

69PUBLICATIONS
75CO-AUTHORS
Predictive and prognostic markersCancer diagnosisMedical infection agents (incl. prions)Haematological tumoursLanguage documentation and description
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (69)

|Jul 03, 2026
Biomarkers in Liver Transplantation for Hepatocellular Carcinoma: Towards Precision Medicine.

|Jun 24, 2026
Sorafenib Restores Pentose Phosphate Pathway-Related Redox Homeostasis via the c-Raf/HSP90/G6PD Axis in Hepatic Ischemia-Reperfusion Injury.

|Jun 19, 2026
An esterase-activated celastrol delivery system suppressed steatosis-related hepatocellular carcinoma progression.

|Jun 03, 2026
The Framework of Precision Pharmacotherapy in Metabolic Dysfunction-Associated Steatohepatitis: A Network Meta-Analysis.

|Apr 15, 2026
Liver transplantation for hepatocellular carcinoma arising in non-cirrhotic liver: a national-wide retrospective cohort study with propensity score matching analysis in China.

Qiang Wei, Nan Xu, Yunguo Lei

|Apr 01, 2026
Selenoprotein P deficiency drives hepatocellular carcinoma progression via induction of neutrophil senescence and immunosuppressive microenvironment.

Jiazheng Jiao, Lele Song, Shengjun Xu

Pageof 12

Frequent Collaborators

13 joint publications

Shusen Zheng

8 joint publications

Di Lu

5 joint publications

Wang Kai

4 joint publications

Qiang Wei